Prasol Chemicals Limited family pacts centralise voting rights

Prasol Chemicals Limited has eight shareholder agreements among family members that channel voting through designated individuals. The agreements, signed from September 20 to September 26, 2017 and amended on March 30, 2022, also address share transfers, non-compete obligations and inheritance-related adherence, while Prasol Chemicals is not a party to them.

What do the eight family shareholder agreements require?

The eight family shareholder agreements require participating relatives to exercise their voting power in the stated manner under the overall direction and supervision of a designated individual for each family. Prasol Chemicals says the arrangements record how family members will vote in respect of the company, transfer shares they own and deal with related matters.

The agreements specifically allow named family members to be authorised to exercise voting rights on behalf of parties to the relevant agreement. This creates a family-level voting mechanism rather than a separate agreement between Prasol Chemicals and its shareholders. Prasol Chemicals states that it has no subsisting shareholder agreement among the company and its shareholders as of the red herring prospectus date.

Each of the eight original agreements was executed between September 20 and September 26, 2017. All eight were amended through amendment agreements dated March 30, 2022. The amendments are material to the treatment of transfer restrictions in connection with the offer for sale and transfers pursuant to the initial public offering.

How do Prasol Chemicals family pacts centralise voting rights?

Prasol Chemicals family pacts centralise voting rights by assigning an authorised individual to each of the eight family groups. The disclosure says family members jointly undertake to exercise their voting power in the agreed manner, subject to the overall direction and supervision of that specified individual.

The mechanism is contractual and applies among the relatives who are parties to each agreement. Prasol Chemicals is not a party to the shareholder agreements or to their amendment agreements, so the company has not itself entered into a contract governing these family members’ voting conduct. The prospectus does not quantify the number of shares held by parties to each agreement or the percentage of company equity covered by each family group.

The disclosure identifies eight separate authorised arrangements, rather than one agreement applicable to all shareholders. One group authorises Dhaval Nalain Parikh, another authorises Sachin Jatin Parikh, while the final listed group authorises Pankil Nishith Dharia jointly with Nishith Rasilakl Dharia. This means the stated coordination is organised through multiple family agreements with separate designated representatives.

A separate agreement dated November 18, 2017 was entered into by the authorised individual of each family and certain other shareholders, under which they agreed, among other matters, to comply with the shareholder agreements. That agreement was amended on April 9, 2022 to record changes in certain parties arising from intra-family arrangements and to support the continued smooth conduct of company business jointly among the families.

What transfer and business restrictions do the agreements contain?

The shareholder agreements contain four principal obligations: voting arrangements, a right of first offer, non-compete provisions and a deed of adherence. The right of first offer gives parties to the relevant agreement an opportunity to acquire equity shares proposed to be transferred at a price determined under an agreed formula.

The deed of adherence applies when equity shares are transmitted following the death of a family member or through inheritance only. Its stated function is to bring the recipient of transmitted shares into the contractual arrangement. The prospectus does not disclose the agreed pricing formula for the right of first offer or the detailed terms of the deed of adherence.

The agreements also include non-compete provisions. These restrict the respective parties from conducting a business substantially similar to, or competing with, the business of Prasol Chemicals. The source does not state the duration, geographical scope or specific product categories covered by the non-compete obligations.

These provisions distinguish voting coordination from restrictions on changes in share ownership and competing activity. The agreements therefore address both how family parties act as shareholders and how shares may move among or beyond the parties, subject to the exceptions later made for the offer for sale and the initial public offering.

What changed under the March 2022 amendments?

The March 30, 2022 amendment agreements waived the right of first offer and the deed-of-adherence requirement for the offer for sale and for transfers made pursuant to Prasol Chemicals’ initial public offering. The disclosed waiver applies to those specified transactions and does not state that the voting arrangements or non-compete provisions were generally removed.

The timing places the amendments after Prasol Chemicals returned to public-company status. Shareholders approved the conversion from Prasol Chemicals Private Limited to Prasol Chemicals Limited on January 15, 2022, and the Registrar of Companies, Maharashtra issued the certificate of change of name on February 4, 2022. The eight family agreements had been in place since September 2017 before the March 2022 amendments.

The amendments affect transfer-related provisions in a defined transaction context. The source does not disclose any subsequent amendment to the eight agreements after March 30, 2022, nor does it state that the agreements have been terminated. Their continuing relevance therefore depends on the terms that remain operative among the family parties.

What rights do the agreements give the company or promoters?

The agreements give no special rights to promoters or shareholders vis-à-vis Prasol Chemicals, according to the prospectus. The company separately states that there are no special rights available to promoters or shareholders, distinguishing the family arrangements from rights granted by the company.

Prasol Chemicals also says the clauses and covenants of the shareholder agreements, as amended, are not adverse or prejudicial to minority and public shareholders. This is the company’s disclosed assessment of the arrangements; the prospectus does not provide an independent measure of their effect on voting outcomes or shareholder decisions.

Beyond the disclosed agreements, Prasol Chemicals says that the company, promoters and shareholders do not have other inter-se agreements or arrangements that are material in nature. It further says there are no other agreements, deeds of assignment, acquisition agreements or agreements of like nature other than those disclosed in the red herring prospectus.

Prasol Chemicals also reports no agreements requiring disclosure under Clause 5A of paragraph A of Part A of Schedule III of the Securities and Exchange Board of India Listing Regulations. That disclosure covers agreements among specified parties or with third parties that directly or indirectly affect management or control, or impose restrictions or liabilities on Prasol Chemicals.

Conclusion

The disclosures show that Prasol Chemicals has eight family-level contracts that organise voting through designated individuals while also covering share-transfer procedures, non-compete commitments and inheritance-related adherence. The arrangements are not company contracts, and Prasol Chemicals says they confer no special rights vis-à-vis the company and are not prejudicial to minority or public shareholders.

The next disclosed point to watch is any amendment, change of parties or termination affecting the agreements that remain after the March 30, 2022 waiver for offer-for-sale and initial-public-offering transfers. Prasol Chemicals has disclosed no other material inter-se shareholder arrangement, while the April 9, 2022 amendment to the separate 2017 agreement recorded changes in certain parties following intra-family arrangements.